We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.
- Authors
Kim, Jong Gwang; Sohn, Sang Kyun; Chae, Yee Soo; Song, Hong Suk; Kwon, Ki-Young; Do, Young Rok; Kim, Min Kyoung; Lee, Kyung Hee; Hyun, Myung Soo; Lee, Won Sik; Sohn, Chang-Hak; Jung, Joo Seop; Kim, Gab Chul; Chung, Ho Young; Yu, Wansik
- Abstract
The present study analyzed the polymorphisms of apoptosis-related genes and their impact on the response to chemotherapy and survival of patients with advanced gastric cancer. Fifty-seven patients with advanced gastric cancer treated with paclitaxel and cisplatin combination chemotherapy were enrolled in the present study. The genomic DNA was extracted from paraffin-embedded tissue, and the single nucleotide polymorphisms (SNPs) of ten apoptosis-related genes [LTA, TP53, BCL2L11, BID, FASL, caspase 3, caspase 6, caspase 7, and caspase 9] determined using a polymerase chain reaction–restriction fragment length polymorphism assay. The Arg/Pro and Pro/Pro genotypes of TP53 codon 72 were significantly correlated with a lower response rate to the combination chemotherapy when compared to the Arg/Arg genotype (35.7 vs. 66.7%, P-value 0.019) in a logistic regression analysis. A multivariate survival analysis also showed that the time to progression for the patients with the Arg/Pro and Pro/Pro genotypes of TP53 codon 72 was worse than for the patients with the Arg/Arg genotype (Hazard ratio = 3.056, P-value = 0.047), whereas the overall survival was not significantly different. The TP53 codon 72 SNP was found to be predictive of the response to chemotherapy and correlate with the time to progression in patients with advanced gastric cancer treated with paclitaxel and cisplatin chemotherapy.
- Subjects
GENETIC polymorphisms; CISPLATIN; PACLITAXEL; STOMACH cancer patients; APOPTOSIS; LOGISTIC regression analysis; COMBINATION drug therapy
- Publication
Cancer Chemotherapy & Pharmacology, 2009, Vol 64, Issue 2, p355
- ISSN
0344-5704
- Publication type
Article
- DOI
10.1007/s00280-008-0879-3